Require makers of implanted devices to set up upkeep plans so the devices keep working even after the company shuts down
Steps to make it happen
- Companies that sell implanted devices promise, before selling them, how many years they will take care of them.
- Each company leaves the plans and programs needed for repairs and updates with a trusted outside organization.
- Each company also sets aside money in a separate fund for emergency repairs and surgery.
- If a company fails or quits, the stored plans and the money go to approved hospitals and technicians.
- People who use the devices can choose for themselves to keep using them or to have them removed safely.
- It becomes normal that a device inside the body does not stop because of what its maker decides.
Water so far 💧 0
The proposal in detail
This proposal covers devices that are implanted in the body or connected to nerves or the brain to support or improve functions such as seeing, hearing, moving, and thinking, and that depend on software updates, outside accessories, or special chargers to work. They include cochlear implants, artificial retinas, and devices that connect the brain to machines, whether they are used to treat illness or to enhance ability. The parties responsible are the regulators in each place who approve the sale and use of devices, and a custodian organization that is independent of the company. Before selling, a company states, in a form users can understand, the minimum maintenance period during which it will keep replacing parts and updating software. It also deposits design documents, the source code of its programs, and the keys and specifications for communicating with external devices with the custodian, and updates them each time it improves the product. In addition, it prepares a reserve fund or insurance to cover the cost of taking over maintenance and the cost of removal surgery if the user wants it. Only when the company can no longer keep its promises, because of bankruptcy, withdrawal, sale of the business, or the like, are the stored materials opened to medical institutions and technicians who pass a review, and they may be used only to keep the devices of current users working. Even after the maintenance period ends, the promise to pay for removal remains. For devices that are used only in clinical trials, the company can instead write into the participants' consent forms exactly how the device will be handled after the trial ends.
BenefitsProtects users' bodies and lives from a company's ups and downs
The biggest benefit is that a person with an implanted device does not suddenly lose the ability to see, hear, or move, even if the company runs into trouble. Because design information and money are prepared in advance, other hospitals and technicians can take over repairs and updates, and people who no longer want to keep the device can choose removal without worrying about the cost. Also, because the maintenance period is shown in advance, patients and families can compare how many years they can count on a device before choosing one. This supports the basic principle of medicine, that people decide for themselves after being informed, over a long span of time as well. Moreover, if cases of users being abandoned keep happening, trust in human enhancement technology as a whole will be damaged, and even truly useful devices may be avoided. Promising a minimum level of security builds a foundation on which society can accept this technology calmly. The stored information can also be used to find and fix safety weaknesses in old devices, so it can be expected to reduce the dangers of devices that stay in use for a long time.
DrawbacksHigher costs may slow the birth and spread of new technology
The point critics see as the most serious is that this duty would be a heavy burden on new companies with little money. Reserve funds, insurance, and the work of continually depositing materials weigh heavily on a company that is not yet making a profit, and if more companies give up trying, devices that could help people now waiting for treatment may arrive later. If the costs are added to the price, the technology may be usable only by wealthy people, which raises the worry of widening inequality. Also, designs and programs are a company's valuable property, and if the deposited information leaks or is used by people with bad intentions, it could end up threatening users' safety instead. There is also a chance that the deposited materials are out of date, or that no technician can be found to take over, so that they are useless when they are needed. Furthermore, if the strictness of the rules differs by country or region, companies may try to sell devices where rules are looser, creating a gap between people who are protected and people who are not. Deciding how much preparation to require is not easy.
Learn the background
Implanted devices are spreading from medicine that makes up for lost hearing or sight to technology that enhances the abilities of the body and mind. Many of these devices stop working properly over time unless the company that made them provides software updates and special external equipment. Yet many companies in this field are new and short of money, and it is not unusual for research or business to be cut off midway. It has actually been reported that when companies stopped their support, some people could no longer get their implanted devices repaired or updated, and either lost their sight again or went on living with a useless device in their bodies. An ordinary appliance can simply be replaced, but a device that has become part of the body cannot be swapped easily, and even taking it out takes surgery. Many current rules focus on checking that a device is safe at the time of sale, and do not fully ask whether it can keep being used years later. Before human enhancement technology spreads further, we need to think about a system in which users' bodies and lives do not depend on where a company's business is heading.
Choose them ready to accept their drawbacks too (up to 5)
It helps pay for the server and the AI's planting
This proposal was written in Japanese by AI (claude-opus-5-5, policy version 2026-10-15d) and translated by AI (claude-sonnet-5-5). Nobody has checked the facts. Read the original (日本語) How the AI writes